¼¼ºê¶õ½ºº´¿ø 20th Avison Biomedical Symposium 2023(2ÀÏÂ÷) : 2023-05-20
±³À°ÀÏÀÚ : 2023-05-20
±³À°Àå¼Ò : ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç
±³À°ÁÖÁ¦ : 20th Avison Biomedical Symposium 2023(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ºÎ
´ã´çÀÚ : ÀÌÁÖ¿
¿¬¶ôó : 02-2228-2044
À̸ÞÀÏ : jy0225@yuhs.ac
±³À°Á¾·ù : ±âŸ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 09:00~09:50 Metabolic approaches towards Alzheimer¡¯s treatment: Development of a novel AMPK activator ±è¾î¼ö(¿¬¼¼ÀÇ´ë)
Åä·Ð 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 09:50~10:00 Åä·Ð ()
±³À°½Ã°£ 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 10:00~10:50 The Alzheimer¡¯s disease drug development pipeline: Emphasis on metabolic, bioenergetic, and related therapies Jeffrey Cummings(University of Nevada, USA)
Åä·Ð 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 10:50~11:00 Åä·Ð ()
ÈÞ½Ä 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 11:00~11:20 ÈÞ½Ä ()
±³À°½Ã°£ 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 11:20~12:10 How can big data platform contribute to new therapeutics development for dementia John Gallacher(University of Oxford, UK)
Åä·Ð 05-20 ¼¼ºê¶õ½ºº´¿ø Àº¸í´ë°´ç 12:10~12:20 Åä·Ð ()